Calendar
Next-Generation Sequencing in Metastatic Breast Cancer: A Game Changer for Asian Patients
This study, led by N2CR members Dr Joline Lim and A/Prof David Tan, looks at the use of next-generation sequencing (NGS) for molecular profiling of metastatic breast cancer (MBC) in
Get to know a professor with over 30 years of experience!
Here’s part 3 of the N2CR Cancer Researchers’ Stories! Let’s get to know Professor Shazib Pervaiz, who is part of the Department of Physiology at the Yong Loo Lin School
Dr Derrick Ong shares more about his work on glioblastomas!
N2CR’s Cancer Researchers’ Stories is back! 👨🔬 👩🔬 Introducing Dr Derrick Ong from the Department of Physiology, as he talks about his current research on glioblastomas and how he balances
A Fun Day Learning about Cancer Research at N2CR!
School’s out but the learning continues! N2CR hosted its very first educational outreach programme, Inspiring Young Minds: A Day in the world of Cancer Research and Healthcare on 27 May
METTL8 links mt-tRNA m3C modification to the HIF1α/RTK/Akt axis to sustain GBM stemness and tumorigenicity
Glioblastoma is the most common and lethal form of adult brain cancer. The presence of cancer stem cells (so-called glioma stem cells) within the tumour, makes it difficult to eradicate
The Inaugural Early Cancer Intervention Symposium 2024 a Success!
And that’s a wrap! A big thank you to everyone who attended the Early Cancer Intervention – From Laboratory Discoveries to the Community Symposium 2024 on 13 – 14 May
director's foreword n2cr
Welcome to the NUS Centre for Cancer Research (N2CR) website!
The N2CR was established in 2020 as one of ten new Translational Research Programmes (TRPs) in the National University of Singapore’s Yong Loo Lin School of Medicine. We are the largest of these Programmes, with over 100 faculty members spanning the basic, translational and clinical sciences.
Professor Ashok Venkitaraman
Director, NUS Centre for Cancer Research
Director, Cancer Science Institute of Singapore
Distinguished Professor of Medicine, Yong Loo Lin School of Medicine, NUS
OUR VISION AND MISSION
of the N2CR is simple
To develop innovative new ways to detect, cure or prevent cancer.
The hallmark of
The Programme
Research Team Of
Tissue-Specific Carcinogenesis
Tissue Specific Carcinogenesis (TSC) focuses on unraveling molecular mechanisms of tissue specific carcinogenesis driving therapy resistance in cancer. The ultimate goal of this Theme is to build an infrastructure and research network that improves how cancer patients are diagnosed, treated and understanding the mechanisms behind therapy resistance in cancer, to identify potential biomarkers of drug resistance/ sensitivity and to identify new targets and treatment modalities to overcome therapy resistance.
A/Prof TAN Shao Peng, David
Theme Lead
Research Team Of
Precision Cancer Medicine
Precision Cancer Medicine (PCM) aims to make diagnosis of cancer simpler and more accurate and ultimately improve treatment. The PCM theme aims to focus research that will identify effective biomarkers, develop new treatment modalities for precision and personalized cancer therapy and create enabling technologies for accurate clinical diagnosis and treatment of specific cancer subtypes and individual cancer patients.
A/Prof CHOW Kai-Hua, Edward
Theme Lead
Research focus is on how to quickly and accurately identify effective cancer therapeutic options for individual cancer patients as well as specific sub-groups of cancer patients in both blood cancers and solid tumours.
Research Team Of
Early Cancer Intervention
Early Cancer Intervention (ECI) focuses on understanding how cell autonomous and non-cell autonomous changes contribute to cancer initiation and relapse post-treatment with the goal of developing innovative approaches to delay, prevent or treat cancer at its earliest stages.
Prof Ashok VENKITARAMAN
Theme Lead
A/Prof Polly CHEN
Theme Lead
some of our trending
News & Events
Discover what matters to you the most.
Next-Generation Sequencing in Metastatic Breast Cancer: A Game Changer for Asian Patients
Jul 11, 2024
Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment
Jul 1, 2024
Macrophage Signatures that Help Predict Lymphoma Patient’s Survival Rate
Jun 14, 2024
PHF2 regulates genome topology and DNA replication in neural stem cells via cohesion
Jun 4, 2024
METTL8 links mt-tRNA m3C modification to the HIF1α/RTK/Akt axis to sustain GBM stemness and tumorigenicity
May 20, 2024
Awardees of the Distinguished Senior Clinician Award 2023
Dec 6, 2023
Yong Loo Lin School of Medicine Excellence Awards for 2023
Jun 27, 2023
A/Prof Polly Chen is nominated as the RNA Society’s Asian Research Ambassador
Apr 28, 2023
ST Singaporean of the Year nominee: A/Prof Too Heng-Phon
Dec 20, 2022
Clarivate Highly Cited Researchers 2022 – Dr Alan Prem Kumar
Dec 19, 2022
Prof Ashok’s message on World Cancer Day 2024
Feb 7, 2024
Prof Alfredo Franco-Obregon and Dr Joline Lim on CNA’s On The Pulse
May 18, 2023
A/Prof Polly Chen is nominated as the RNA Society’s Asian Research Ambassador
Apr 28, 2023
Novel stem cell therapy for cancer-stricken pets
Jan 17, 2023
N2CR members conduct liver transplant for stage 4 cancer patient
Oct 5, 2022
Coming Soon
be part of us
Find The Best Positions For You
Join us and be a part in shaping Singapore's healthcare for the future!
Research Fellow – Dr Shruti Bhatt’s lab
We are seeking a full-time post-doctoral fellow in the leukemia biology laboratory of Dr. Shruti Bhatt in the Department of Pharmacy at the National University of Singapore, Singapore. We are looking for candidates who share our …
Research Fellow – A/Prof Glenn Bonney’s lab
The National University of Singapore invites applications for a Research Fellow position in the Department of Surgery, Yong Loo Lin School of Medicine. The Department of Surgery is a family of 14 sub-specialties that deliver …
Research Fellow – Dr Gloryn Chia’s lab
We are seeking highly motivated Research Fellows with keen interest and expertise in immunology, oncology and/or bioinformatics. Our team aims to leverage on stem cell biology (Sagi, Chia et. al., Nature 2016; Chia et. al., …